Post-exercise oxidative stress and obesity in postmenopausal women: The role of β3-adrenergic receptor polymorphism

Gynecological Endocrinology

Volumn 23, Issue 10, 2007, Pages 597-603

  Lwow, Felicja ^a   Dunajska, Katarzyna ^a   Tworowska, Urszula ^b   Jȩdrzejuk, Diana ^b   Łaczmański, Łukasz ^b   Milewicz, Andrzej ^a   Szmigiero, Leszek ^c  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

3 Adrenergic receptor; Obesity; Oxidative stress; Postmenopausal women

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRYPTOPHAN;

ADULT; ANTHROPOMETRY; ARTICLE; BICYCLE ERGOMETER; BLOOD ANALYSIS; BODY FAT; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDURANCE; EXERCISE; EXERCISE TEST; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID STORAGE; MAJOR CLINICAL STUDY; MEASUREMENT; OBESITY; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL;

EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RECEPTORS, ADRENERGIC, BETA-3;

EID: 35348994793     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09638280701565110     Document Type: Article

References (60)

1. Sherman SE, D'Agostino RB, Cobb JL, Kannel WB. Physical activity and mortality in women in the Framingham Heart Study. Am Heart J 1994;128:879-884.
2. Tremblay MS, Chu SY. Hormonal response to exercise. In: Warren PM, Constantini NW, editors. Sports endocrinology. Totowa (NJ): Humana Press Inc.; 2000. pp 1-30.
3. Wade CE. Hormonal regulation of fluid homeostasis during and following exercise. In: Warren PM, Constantini NW, editors. Sports endocrinology. Totowa (NJ): Humana Press Inc.; 2000. pp 207-225.
4. Gleim GW, Glace BW. Energy balance and weight control (male and female). In: Warren PM, Constantini NW, editors. Sports endocrinology. Totowa (NJ): Humana Press Inc.; 2000. pp 189-205.
5. Bjorntrop P. Abdominal obesity and the development of noninsulin dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615-622.
6. Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1989;5:83-109.
7. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1567.
8. Hubert HB, Fenileb M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983;67:968-977.
9. Welin L, Eriksson H, Larsson B, Svardsudd K, Wilhelmsen L, Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology 1993;82:223-228.
10. Larsson B, Bengtsson C, Bjorntorp P, Lapidus L, Sjostrom L, Svardsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen L. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 1992;135:266-273.
11. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J, Warden CH, Pecqueur C, Raimbault S, et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 1998;7:1431-1435.
12. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
13. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in genetic regulator of adipocyte differentiation. N Engl J Med 1998;339:953-959.
14. Sheng B, Moran TH. Actions of CCK in the controls of food intake and body weight: lessons from the CCK-A receptor deficient OLETF rat. Neuropeptides 2002;36:171-181.
15. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med 2003;54:453-471.
16. Tchernof A, Starling RD, Walston JD, Shuldiner AR, Dvorak RV, Silver K, Matthews DE, Poehlman ET. Obesity-related phenotypes and the β3-adrenoceptor gene variant in postmenopausal women. Diabetes 1999;48:1425-1428.
17. Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD. Genetic variation in the β3 adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:322-354.
18. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N, et al. Time of onset of non-insulin- dependent diabetes mellitus and genetic variation in the β3 adrenergic receptor gene. N Engl J Med 1995;333:343-347.
19. Widen E, Lehto M, Kanninen T, Walston J, Shuydiner AR, Groop LC. Association of a polymorphism in the β3 adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
20. Shima Y, Tsukada T, Nakanishi K, Ohta H. Association of the Trp64Arg mutation of the β3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta 1998;274:167-176.
21. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Metaanalysis of the association of Trp64Arg polymorphism of β3 adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998;83:2441-2444.
22. Mitchell BD, Blangero J, Comuzzie AG, Almasy LA, Shuldiner AR, Silver K, Stern MP, MacCluer JW, Hixson JE. A paired sibling analysis of the β3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998;101:584-587.
23. Mitchell BD, Cole SA, Comuzzie AG. A quantitative trait locus influencing BMI maps to the region of the β3 adrenergic receptor. Diabetes 1999;48:1863-1867.
24. Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT, Oppert JM, Perusse L, Sjostrom L, Bouchard C. The Trp64Arg mutation of the β3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996;98:2086-2093.
25. Garcia Rubi E, Calles-Escandon J. Insulin resistance and type 2 diabetes mellitus: its relationship with the β3 adrenergic receptor. Arch Med Res 1999;30:459-464.
26. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, et al. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1785-1791.
27. Elosua R, Molina L, Fito M, Arquer A, Sanchez-Quesada JL, Covas MI, Ordoñez-Llanos J, Marrugat J. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 2003;167:327-334.
28. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001;86:355-362.
29. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: mechanism of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord 2002;26:754-764.
30. Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 2005;50:31-33.
31. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
32. Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type I diabetes mellitus. J Clin Endocrinol Metab 2002;87:1036-1040.
33. Wasserman K, Hansen JE, Sue DY, Whipp B, editors. Principles of exercise testing and interpretation. Philadelphia (PA): Lea & Febiger; 1987. 73 pp.
34. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987;366:1-15.
35. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251-256.
36. Lapenna D, Ciofani G, Pierdomenico SD, Giamberardino MA, Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001;31:331-335.
37. Matsushita H, Kurabayashi T, Tomita M, Kato N, Tanaka K. Effects of uncoupling protein 1 and β3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women. Maturitas 2003;45:39-45.
38. Hao K, Peng S, Xing H, Yu Y, Huang A, Hong X, Wang Y, Chen C, Wang B, Zhang X, et al. β3 Adrenergic receptor polymorphism and obesity related phenotypes in hypertensive patients. Obes Res 2004;12:125-130.
39. Kasznicki J, Blasiak J, Majsterek I, Przyby?owska K, Drzewoski J. The Trp64Arg β3-adrenergic receptor aminoacid variant is not associated with overweight and type 2 diabetes mellitus in Polish population. Exp Clin Endocrinol Diabetes 2005;113:593-597.
40. Büettner R, Schäffler A, Arndt H, Rogler G, Nusser J, Zietz B, Enger I, Hügl S, Cuk A, Schölmerich J, et al. The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998;83:2892-2897.
41. Endo K, Yanagi H, Hirano C, Hamaguchi H, Tsuchiya S, Tomura S. Association of Trp64Arg polymorphism of the β3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord 2000;24:443-449.
42. Arashiro R, Katsuren K, Fukuyama S, Ohta T. Effect of Trp64Arg mutation of the β3-adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor γ gene polymorphism of the leptin receptor gene in Japanese children. Paediatr Int 2003;45:135-141.
43. Kurokawa N, Nakai K, Kameo S, Liu ZM, Satoh H. Association of BMI with the β3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 2001;9:741-745.
44. Shiwaku K, Nogi A, Anuurad E, Kitajima K, Enkhmaa B, Shimono K, Yamane Y. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the β3-adrenergic receptor gene. Int J Obes Relat Metab Disord 2003;27:1028-1036.
45. Corella D, Guillén M, Portolés O, Sorlí JV, Alonso V, Folch J, Sáiz C. Gender specific associations of the Trp64Arg mutation in the β3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med 2001;250:348-360.
46. Evans D, Minouchehr S, Hagemann G, Mann WA, Wendt D, Wolf A, Beisiegel U. Frequency of and interaction between polymorphisms in the β3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes Relat Metab Disord 2000;24:1239-1245.
47. Okumura K, Matsui H, Ogawa Y, Takahashi R, Matsubara K, Imai H, Imamura A, Mizuno T, Tsuzuki M, Kitamura Y. The polymorphism of the β3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size. Metabolism 2003;52:356-361.
48. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;14:1752-1761.
49. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003;88:4673-4676.
50. Vincent HK, Vincent KR, Bouguignon C, Braith RW. Obesity and postexercise oxidative stress in older women. Med Sci Sport Exerc 2005;37:213-219.
51. Garrow JS, Summerbell CD. Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects. Eur J Clin Nutr 1995;49:1-10.
52. Wing RR. Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999;31:547-552.
53. Fleming RM. The effect of high-, moderate-, and low-fat diets on weight loss and cardiovascular disease risk factors. Prev Cardiol 2002;5:110-118.
54. Miller WC. How effective are traditional dietary and exercise interventions for weight loss? Med Sci Sports Exerc 1999;31:1129-1134.
55. Miller WC. Effective diet and exercise treatments for overweight and recommendations for intervention. Sports Med 2001;31:717-724.
56. Ji LL. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med 1999;222:283-292.
57. Leeuwenburgh C, Heincke JW. Oxidative stress and antioxidants in exercise. Curr Med Chem 2001;8:829-838.
58. Tsai K, Hsu, Hsu KM, Cheng H, Liu TY, Hsu CF, Kong CF. Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radic Biol Med 2001;31:1465-1472.
59. Jenkins RR, Friedland R, Howald H. The relationship of oxygen uptake to superoxide dismutase and catalase activity in human skeletal muscle. Int J Sports Med 1984;5:11-14.
60. Bar PR, Amelink GJ. Protection against muscle damage exerted by oestrogen: hormonal or antioxidant action? Biochem Soc Trans 1997;25:50-54.